Life Science (UK) Price Prediction
| LABS Stock | 38.60 0.10 0.26% |
Oversold Vs Overbought
47
Oversold | Overbought |
Quarterly Earnings Growth (0.24) | EPS Estimate Current Year 0.0151 | EPS Estimate Next Year 0.021 | Wall Street Target Price 52.333 | Quarterly Revenue Growth 0.018 |
Using Life Science hype-based prediction, you can estimate the value of Life Science REIT from the perspective of Life Science response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Life Science to buy its stock at a price that has no basis in reality. In that case, they are not buying Life because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Life Science after-hype prediction price | GBX 38.19 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Life |
Life Science After-Hype Price Prediction Density Analysis
As far as predicting the price of Life Science at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Life Science or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Life Science, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Life Science Estimiated After-Hype Price Volatility
In the context of predicting Life Science's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Life Science's historical news coverage. Life Science's after-hype downside and upside margins for the prediction period are 36.06 and 40.32, respectively. We have considered Life Science's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Life Science is very steady at this time. Analysis and calculation of next after-hype price of Life Science REIT is based on 3 months time horizon.
Life Science Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Life Science is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Life Science backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Life Science, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.34 | 2.13 | 0.41 | 1.35 | 3 Events / Month | 2 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
38.60 | 38.19 | 1.06 |
|
Life Science Hype Timeline
Life Science REIT is now traded for 38.60on London Exchange of UK. The entity has historical hype elasticity of -0.41, and average elasticity to hype of competition of 1.35. Life is projected to decline in value after the next headline, with the price expected to drop to 38.19. The average volatility of media hype impact on the company price is about 177.5%. The price decline on the next news is expected to be -1.06%, whereas the daily expected return is now at 0.34%. The volatility of related hype on Life Science is about 53.6%, with the expected price after the next announcement by competition of 39.95. About 70.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.51. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Life Science REIT recorded a loss per share of 0.11. The entity last dividend was issued on the 3rd of October 2024. Assuming the 90 days trading horizon the next projected press release will be in about 3 days. Check out Life Science Basic Forecasting Models to cross-verify your projections.Life Science Related Hype Analysis
Having access to credible news sources related to Life Science's direct competition is more important than ever and may enhance your ability to predict Life Science's future price movements. Getting to know how Life Science's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Life Science may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| DLN | Derwent London PLC | (83.00) | 2 per month | 0.00 | (0.29) | 1.25 | (1.84) | 7.03 | |
| HMSO | Hammerson PLC | (3.80) | 4 per month | 0.00 | (0.13) | 2.01 | (2.62) | 8.58 | |
| WKP | Workspace Group PLC | (16.00) | 4 per month | 0.00 | (0.26) | 2.01 | (3.03) | 8.98 | |
| SUPR | Supermarket Income REIT | (3.10) | 4 per month | 0.00 | (0.15) | 1.71 | (1.45) | 5.97 | |
| 0K2K | Molson Coors Beverage | (0.72) | 4 per month | 0.94 | 0.06 | 2.56 | (1.66) | 7.75 | |
| XLM | XLMedia PLC | (2.25) | 1 per month | 3.49 | (0) | 2.63 | (2.50) | 50.54 | |
| 0HW4 | Charter Communications Cl | 4.75 | 1 per month | 2.24 | 0.04 | 3.38 | (3.43) | 19.79 | |
| 0HOY | Boston Scientific Corp | (0.15) | 2 per month | 0.78 | 0.06 | 1.42 | (1.63) | 6.85 | |
| RIO | Rio Tinto PLC | 144.00 | 2 per month | 0.00 | (0.04) | 3.13 | (2.00) | 9.45 | |
| PREM | Premier African Minerals | 0.01 | 1 per month | 7.96 | 0.04 | 15.38 | (9.46) | 70.70 |
Life Science Additional Predictive Modules
Most predictive techniques to examine Life price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Life using various technical indicators. When you analyze Life charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Life Science Predictive Indicators
The successful prediction of Life Science stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Life Science REIT, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Life Science based on analysis of Life Science hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Life Science's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Life Science's related companies.
Story Coverage note for Life Science
The number of cover stories for Life Science depends on current market conditions and Life Science's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Life Science is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Life Science's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Life Science Short Properties
Life Science's future price predictability will typically decrease when Life Science's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Life Science REIT often depends not only on the future outlook of the potential Life Science's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Life Science's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 350 M | |
| Cash And Short Term Investments | 14.3 M |
Additional Tools for Life Stock Analysis
When running Life Science's price analysis, check to measure Life Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Life Science is operating at the current time. Most of Life Science's value examination focuses on studying past and present price action to predict the probability of Life Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Life Science's price. Additionally, you may evaluate how the addition of Life Science to your portfolios can decrease your overall portfolio volatility.